Prediction and structural equation model of sertraline treatment response in Japanese patients with major depressive disorder

被引:4
|
作者
Nishioka, Gentaro [1 ,2 ,3 ]
Yashima, Hideaki [4 ,5 ]
Kiuchi, Yuji [8 ]
Nakamura, Sumiko [4 ,6 ]
Oyamada, Hideto [7 ]
Ishii, Masakazu [4 ]
Kudo, Ikuo [2 ]
机构
[1] Tokyo Metropolitan Police Hosp, Dept Psychiat, Tokyo 1648541, Japan
[2] Showa Univ, Northern Yokohama Hosp, Dept Psychiat, Yokohama, Kanagawa, Japan
[3] Kawaguchi Hosp, Kawaguchi, Saitama, Japan
[4] Showa Univ, Sch Pharmaceut Sci, Dept Pathophysiol, Tokyo 142, Japan
[5] Gunma Univ Hosp, Dept Pharmaceut, Maebashi, Gunma, Japan
[6] Tokyo Koseinenkin Hosp, Dept Pharmaceut, Tokyo, Japan
[7] Showa Univ, Sch Med, Dept Pharmacol, Tokyo 142, Japan
[8] Showa Univ, Sch Pharmaceut Sci, Ctr Pharmaceut Educ, Tokyo 142, Japan
关键词
major depressive disorder; sertraline treatment response; 5HTTSTin2; personality; recurrence; structural equation model; STAR-ASTERISK-D; LIFE EVENTS; AGED; 75; PERSONALITY; POLYMORPHISM; GENE; TEMPERAMENT; SENSITIZATION; INTEGRATION; RECURRENCE;
D O I
10.1002/hup.2347
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ObjectiveThe aim of this study was to extract the factors possibly associated with sertraline treatment response and elucidate their interactions and extent of influence. MethodsDemographic state, stress state, personality, and eight genetic polymorphisms at baseline and clinical symptoms at baseline and 8weeks were analyzed and examined by logistic regression and a structural equation model in sertraline treatment study of 96 Japanese patients with major depressive disorder. ResultsNon-responders were associated with higher scores of harm avoidance in Temperament and Character Inventory, higher scores (24) of 17-item Hamilton Rating Scale for Depression at baseline, recurrence, and 12/12 genotype of the serotonin transporter variable number of tandem repeat polymorphism in intron 2 (5HTTSTin2). When we calculated the response index using four factors extracted, the mean response index value of non-responders was significantly higher than that of responders. The symptoms at baseline, personality, recurrence, and polymorphism of 5HTTSTin2 showed significantly direct and positive influences on the symptoms at 8weeks in our final structural equation model with a good model fit. ConclusionConsidering the combination of four factors extracted may be useful for predicting a worse response to sertraline treatment and selecting different treatment other than sertraline. Copyright (c) 2013 John Wiley & Sons, Ltd.
引用
收藏
页码:576 / 585
页数:10
相关论文
共 50 条
  • [1] EEG Biomarkers to Predict Response to Sertraline and Placebo Treatment in Major Depressive Disorder
    Oakley, Thomas
    Coskuner, Jonathan
    Cadwallader, Andrew
    Ravan, Maryam
    Hasey, Gary
    [J]. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2023, 70 (03) : 909 - 919
  • [2] Cerebral Blood Perfusion Moderates Treatment Response to Sertraline in Major Depressive Disorder
    Cooper, Crystal M.
    Fatt, Cherise R. Chin
    Jha, Manish
    Fonzo, Gregory
    Grannemann, Bruce D.
    Carmody, Thomas
    Ali, Aasia
    Aslan, Sina
    Almeida, Jorge R. C.
    Deckersbach, Thilo
    Fava, Maurizio
    Kurian, Benji T.
    McGrath, Patrick J.
    McInnis, Melvin
    Parsey, Ramin V.
    Weissman, Myrna
    Phillips, Mary
    Lu, Hanzhang
    Etkin, Amit
    Trivedi, Madhukar H.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2019, 254 : 137 - 137
  • [3] Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline
    Thase, ME
    Blomgren, SL
    Birkett, MA
    Apter, JT
    Tepner, RG
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 1997, 58 (01) : 16 - 21
  • [4] CLOCK may Predict the Response to Fluvoxamine Treatment in Japanese Major Depressive Disorder Patients
    Kishi, Taro
    Kitajima, Tsuyoshi
    Ikeda, Masashi
    Yamanouchi, Yoshio
    Kinoshita, Yoko
    Kawashima, Kunihiro
    Okochi, Tomo
    Okumura, Takenori
    Tsunoka, Tomoko
    Ozaki, Norio
    Iwata, Nakao
    [J]. NEUROMOLECULAR MEDICINE, 2009, 11 (02) : 53 - 57
  • [5] CLOCK may Predict the Response to Fluvoxamine Treatment in Japanese Major Depressive Disorder Patients
    Taro Kishi
    Tsuyoshi Kitajima
    Masashi Ikeda
    Yoshio Yamanouchi
    Yoko Kinoshita
    Kunihiro Kawashima
    Tomo Okochi
    Takenori Okumura
    Tomoko Tsunoka
    Norio Ozaki
    Nakao Iwata
    [J]. NeuroMolecular Medicine, 2009, 11 : 53 - 57
  • [6] A comparison of the response to sertraline in children and adolescents with major depressive disorder
    Donnelly, CL
    Ambrosini, P
    Wagner, KD
    Rynn, M
    Landau, P
    Wohlberg, CJ
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2003, 13 (04) : 418 - 419
  • [7] Efficacy and response time to sertraline versus fluoxetine in the treatment of unipolar major depressive disorder
    Suri, RA
    Altshuler, LL
    Rasgon, NL
    Calcagno, JL
    Frye, MA
    Gitlin, MJ
    Hwang, S
    Zuckerbrow-Miller, J
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 (12) : 942 - 946
  • [8] PREDICTION OF TREATMENT RESPONSE TO EXERCISE IN ADULTS WITH MAJOR DEPRESSIVE DISORDER
    Brush, Christopher J.
    Ehmann, Peter J.
    Alderman, Brandon L.
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2018, 52 : S769 - S769
  • [9] Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder
    Mathews, M
    Mathews, M
    Mathews, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (01): : 40 - 40
  • [10] Psychomotor Changes in Major Depressive Disorder during Sertraline Treatment
    Schrijvers, D.
    Maas, Y. J.
    Pier, M. P. B. I.
    Madani, Y.
    Hulstijn, W.
    Sabbe, B. G. C.
    [J]. NEUROPSYCHOBIOLOGY, 2009, 59 (01) : 34 - 42